These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14096418)

  • 21. [CYTOSTATIC EFFECTS OF N-AND S-HYDROXYMETHYL AND N-C-N COMPOUNDS].
    WEITZEL G; SCHNEIDER F; FRETZDORFF AM; SEYNSCHE K; FINGER H
    Z Naturforsch B; 1963 Dec; 18():1121-2. PubMed ID: 14120068
    [No Abstract]   [Full Text] [Related]  

  • 22. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1017+. PubMed ID: 14278900
    [No Abstract]   [Full Text] [Related]  

  • 23. THE DURATION OF THE MYELOTOXIC EFFECTS OF CIRCULATING ALKYLATING AGENTS.
    ULFOHN A; KRAMER SP; DORFMAN H; WITTEN B; WILLIAMSON C; SASS S; MILLER JI; SELIGMAN AM
    Cancer Res; 1964 Oct; 24():1659-65. PubMed ID: 14234010
    [No Abstract]   [Full Text] [Related]  

  • 24. MUTAGENICITY OF A MONOFUNCTIONAL ALKYLATING AGENT DERIVATIVE OF ACRIDINE IN NEUROSPORA.
    BROCKMAN HE; GOBEN W
    Science; 1965 Feb; 147(3659):750-1. PubMed ID: 14242025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract]   [Full Text] [Related]  

  • 26. ENZYME-ALTERABLE ALKYLATING AGENTS. VII. THE DESIGN OF SHORT-LIVED MUSTARDS.
    SASS S; WILLIAMSON CE; KRAMER SP; GOODMAN LE; ULFOHN A; SELIGMAN AM; WITTEN B
    J Med Chem; 1965 Jan; 8():14-7. PubMed ID: 14287258
    [No Abstract]   [Full Text] [Related]  

  • 27. THE EFFECTS OF ALKYLATING AGENTS ON FERTILITY.
    JACKSON H
    Br Med Bull; 1964 May; 20():107-14. PubMed ID: 14171898
    [No Abstract]   [Full Text] [Related]  

  • 28. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS.
    BOYLAND E; KINDER CH; WILLIAMS K
    Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785
    [No Abstract]   [Full Text] [Related]  

  • 29. Enzyme-alterable alkylating agents. IV. Treatment of cancer in children with repetitive massive doses of S-46, protecting the extremity marrow by tourniquets.
    SCHILLING A
    Cancer; 1963 Jun; 16():727-36. PubMed ID: 13991706
    [No Abstract]   [Full Text] [Related]  

  • 30. [NITROGEN MUSTARDS AS ALKYLATING AGENTS].
    MANACORDA G; POMINI A
    Minerva Farm; 1964; 13():89-94. PubMed ID: 14268580
    [No Abstract]   [Full Text] [Related]  

  • 31. OPTICAL STEREOSPECIFICITY OF ANTI-CANCER AGENTS.
    BERGEL F
    Farmaco Sci; 1964 Jan; 19():99-109. PubMed ID: 14129560
    [No Abstract]   [Full Text] [Related]  

  • 32. EFFECT OF ALKYLATING AGENTS AND WHOLE-BODY X-IRRADIATION ON THYMUS.
    HERRANEN A
    Nature; 1964 Aug; 203():891-2. PubMed ID: 14204093
    [No Abstract]   [Full Text] [Related]  

  • 33. [TUMOR CHEMOTHERAPY. XXIX. STUDIES ON BIS-(BETA-CHLOROETHYL)-AMINOMETHYLPHENYLALANINE. 2. SYNTHESIS OF 2-BIS-(BETA-CHLOROETHYL)-AMINOMETHYL-5-NITROPHENYLALANINE].
    JEN YF; YANG TS
    Yao Xue Xue Bao; 1965 Apr; 12():267-71. PubMed ID: 14327988
    [No Abstract]   [Full Text] [Related]  

  • 34. [THE INFLUENCE ON CARBOHYDRATE METABOLISM OF TUMORS OF CHOMOTHERAPEUTIC DRUGS].
    KROEGER H
    Z Naturwiss Med Grundlagenforsch; 1963 Apr; 1():126-42. PubMed ID: 14159165
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of the action of ionizing radiations and biological alkylating agents (nitrogen mustards) at the cellular and sub-cellular level.
    ALEXANDER P
    Sci Rep Ist Super Sanita; 1961 Oct; 1():537-50. PubMed ID: 13860356
    [No Abstract]   [Full Text] [Related]  

  • 36. Enzyme activated anti-tumour agents--III. Hydrolysis of conjugates of p-hydroxyaniline mustard in aqueous solution.
    Workman P; Double JA; Wilman DE
    Biochem Pharmacol; 1976 Nov; 25(21):2347-50. PubMed ID: 999722
    [No Abstract]   [Full Text] [Related]  

  • 37. [CHEMOTHERAPY OF CANCER. V. SYNTHESIS OF SEVERAL PHENYLALANINES CONTAINING BIS-(2-CHLOROETHYL)AMINO GROUP].
    YUEN CY; CHANG CN; CHEN PZ; YIH YF; CHOW HL
    Yao Xue Xue Bao; 1964 Jan; 11():15-22. PubMed ID: 14125832
    [No Abstract]   [Full Text] [Related]  

  • 38. DENTAL LESIONS IN RAT INDUCED BY RADIOMIMETIC AGENTS.
    HEBBORN P; MISHRA LC; DALTON C; WILLIAMS JP
    Arch Pathol; 1965 Aug; 80():110-5. PubMed ID: 14326433
    [No Abstract]   [Full Text] [Related]  

  • 39. Reduction of the toxicity of radiomimetic alkylating agents in rats by thiol pretreatment. V. The effect of thiol pretreatment on the anti-tumour action of Merophan.
    Connors TA; Jenney A; Whisson ME
    Biochem Pharmacol; 1965 Nov; 14(11):1681-3. PubMed ID: 5867521
    [No Abstract]   [Full Text] [Related]  

  • 40. GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
    BOOTH BA; SARTORELLI AC
    Cancer Res; 1963 Dec; 23():1762-8. PubMed ID: 14082870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.